NeuroPace (NPCE) Stock Price, Quote, News & History | Benzinga

NeuroPace Inc (NPCE) Stock Price, Quote, News & History

NPCENASDAQ

Trade with Public

Trade with Public

$14.13

-0.55-3.75%

At close: Aug 27, 5:00 PM EST

$14.13

N/A

After Hours: 4:28 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$14.60

Close

$14.13

Volume / Avg.

148.09K / 187.64K

Day Range

$14.07 - $14.81

52 Wk Range

8.61 - 19.60

Market Cap

$485.00M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

45

Short Interest

2.83%

Days to Cover

3.34

Recent NeuroPace, Inc. News

Avis Budget Posts Weak Q2 Results, Joins Fiverr International, Costar Group And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

US stock futures mixed, Dow up 0.1%. Avis Budget Group (CAR) shares down 13.3% after missing earnings & sales estimates. Other stocks also down.

Avi Kapoor

Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Benzinga Senior Editor

This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Why Is NeuroPace Stock Falling After Epilepsy Treatment Study Data?

NeuroPace's RNS System trial showed a strong safety profile and subgroup efficacy in drug-resistant epilepsy, prompting FDA pathway discussions.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-11.24M

Investing Cash Flow (TTM)

-369.00K

Financing Cash Flow (TTM)

1.41M

Free Cash Flow (TTM)

-11.61M

Capital Expenditure (TTM)

-369.00K

Net Change in Cash (TTM)

-10.20M

Analyst Trends and Forecast

1

May

2

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$521.77M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

4.61

PB Ratio (TTM)

42.37

Earnings Yield % (TTM)

-3.20%

Earnings Yield % (FWD)

-4.57%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.35

Company Debt

Total Debt

$59.01M

LT Debt

$59.01M

LT Debt Issuance (TTM)

-$133.00K

LT Debt Repayment (TTM)

$0

Total Cash

$12.54M

Debt to Equity

5.88

Issuance of Debt (TTM)

-$133.00K

Repayment of Debt (TTM)

$0

Key Statistics

Open

$14.60

Close

$14.13

Volume / Avg.

148.09K / 187.64K

Day Range

$14.07 - $14.81

52 Wk Range

8.61 - 19.60

Market Cap

$485.00M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

45

Short Interest

2.83%

Days to Cover

3.34

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that contin...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy NeuroPace (NPCE) stock?

A

You can purchase shares of NeuroPace (NASDAQ:NPCE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are NeuroPace (NPCE) competitors?

A

Other companies in NeuroPace’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Stryker Corp (NYSE:SYK), Medtronic PLC (NYSE:MDT) and Boston Scientific Corp (NYSE:BSX).

Q

What is the forecast, or price target, for NeuroPace (NPCE) stock?

A

NeuroPace has a consensus price target of $17.67.

Q

What is the current price for NeuroPace (NPCE)?

A

The stock price for NeuroPace (NASDAQ: NPCE) is $14.13 last updated August 27, 2026 at 4:28 PM EDT.

Q

Does NeuroPace (NPCE) pay a dividend?

A

There are no upcoming dividends for NeuroPace.

Q

When is NeuroPace (NASDAQ:NPCE) reporting earnings?

A

NeuroPace does not have any upcoming earnings scheduled.

Q

Is NeuroPace (NPCE) going to split?

A

There is no upcoming split for NeuroPace.

Q

What sector and industry does NeuroPace (NPCE) operate in?

A

NeuroPace is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.